The Proteomics Market To Encash On Digital Programs For Patients

The global Proteomics Market is expected to grow on an impertinent note in the next 10 years. It could witness a CAGR of 17% and reach US$ 26 Bn by 2022. Over the years, the proteomics market has created new opportunities in life science industries due to increasing usage of the technology in cancer drug development and personalized medicine. As per findings of Persistence Market Research (PMR), the global market for proteomics will witness stupendous expansion at a CAGR of 17% over the forecast period (2019-2029).

Get Sample Of Proteomics Market Report@ https://www.persistencemarketresearch.com/samples/31378

With growth projected to showcase over 5X expansion in revenues, the global proteomics market remains buoyed by advancements in high-throughput technologies that are constantly being used to investigate proteomes. As proteomics are widely used in diagnostics, prognostics, and various other healthcare applications, there has been increasing demand for proteomic techniques in disease diagnostics and drug development.

Companies covered in Proteomics Market Report

Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc. (US)
GE Healthcare (US)
Danaher Corporation (US)
PerkinElmer, Inc. (US)
Merck KGaA (Germany)
Caprion Proteomics Inc.
Bio-Rad Laboratories
Luminex Corporation (US)
Waters Corporation
Promega Corporation
User Corporation

Switch Over To The "Methodology" Tab@ https://www.persistencemarketresearch.com/methodology/31378

Key Takeaways of Proteomics Market Study

The reagents and kits segment under component is expected to contribute more than 30% of revenue share in the proteomics market.

In terms of technology, the protein fractionation systems segment is expected to grow twice its size by the end of 2029.

Leading proteomics service provider companies are collaborating with local proteomics service providers as well as research institutes to strengthen their market position.

North America is dominating the global proteomics market, while East Asia is expected to offer lucrative opportunities, owing to rapid increasing healthcare programs and industrialization in the region.

"Technological advancements in proteomic techniques and growing demand for proteomics research for drug development focusing on large-scale manufacturing of personalized medicine are bringing in new avenues for market development," says a PMR analyst.

Go To Purchase Now@ https://www.persistencemarketresearch.com/checkout/31378

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About us:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.